Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of APH1B mRNA | affects expression | 21346803
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of APH1B mRNA | increases expression | 20678512
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of APH1B mRNA | affects cotreatment|affects expression | 17602206
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of APH1B mRNA | affects cotreatment|affects expression | 17602206
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of APH1B mRNA | increases expression | 19638242
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of APH1B mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of APH1B mRNA | affects binding|increases activity|increases expression | 19710929
|
D013749 |
Tetrachlorodibenzodioxin |
AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of APH1B mRNA] | affects reaction|increases expression | 16214954
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of APH1B mRNA | increases expression | 16214954
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.31 | 14514962 15322242 11752688 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.47 | 18653653 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
3.01 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
20.17 | 19052882 16434500 17620307 19061943 17162532 18056438 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
20.17 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
20.17 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.25 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.87 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.87 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.95 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.19 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.86 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.86 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.86 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.11 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
3.11 | 16807293 16698587 3581430 19107877 20935162 16540662 18785209 20101231 19394651 16328049 18506893 18691550 20524982 11831363 20084675 20214788 20007298 18056438 17428255 18971187 19519916 20432363 19335982 18665156 17761372 18494052 19171122 16681979 17055752 16779866 17978847 16935385 19539802 10737359 18393292 21159647 19052882 19822196 10672840 19418558 19701751 16569478 17173139 16502159 20514400 19383236 16288022 19208518 3084413 18978308 18788625 20512989 19919837 16830150 16878318 20727157 18210153 17162532 17138121 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.45 | 17123778 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.52 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.39 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
7.39 | 21159647 17174075 2727394 7505956 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
10.29 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
10.29 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.05 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.21 | 12621046 8697196 15340226 15668235 16354765 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 20055451 15322242 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.44 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.55 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.43 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.43 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.63 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.63 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.63 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.99 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.63 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.63 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.42 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.33 | 10568697 9294722 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.64 | 16302075 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
8.78 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.78 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.87 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.36 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.12 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.47 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.71 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.66 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.69 | 16221962 18467677 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.69 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.57 | 16354765 18606429 16959395 15340226 8697196 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.49 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.00 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
5.38 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.38 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.96 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.96 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.66 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.24 | 16705839 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.98 | 19638242 18665156 18407596 20032147 18522880 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.21 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.21 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.16 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
15.33 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
15.33 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
15.33 | 19690152 10737359 12112319 19833225 18754104 19638242 20137499 21047994 12771043 9163691 19426721 16942905 18644402 20452335 18978307 19812893 18977376 20492335 19255062 19256749 15175105 19499222 21071580 21278145 19850985 19427195 20118626 20405173 2862719 20434301 20101389 19073162 19090486 19996281 18648771 15885732 19642983 20501860 20583210 19551842 2422723 21167192 19294768 19254457 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
15.33 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
15.33 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
10.87 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
10.87 | 19126423 19009564 18253720 16267830 18093689 19539802 18079962 17854601 18544905 17174075 18775883 21159647 18164116 19004024 17942915 18282651 3124819 9362446 2563599 19519916 18308698 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.87 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.33 | 20970405 21163286 6695378 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.33 | 19555203 11884234 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.92 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.25 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.27 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.19 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.32 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.67 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.08 | 17405874 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
10.88 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.88 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.61 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.64 | 20387270 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.87 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.74 | 16049721 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.45 | 11985600 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.51 | 16540662 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.77 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.94 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.84 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
11.10 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
11.10 | 11896295 11399792 11118676 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.53 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.36 | 16740699 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
5.25 | 10548101 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.52 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.22 | 18990726 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.74 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.17 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.45 | 16684133 16045194 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.42 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.22 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.39 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.78 | 10091137 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.53 | 14652134 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.12 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.77 | 15886252 |